
Dyadic has signed an OEM distribution agreement with IBT Bioservices to commercialize Dyadic-produced recombinant proteins through IBT’s global research channels.
Initial RUO products are expected to include recombinant DNase I and transferrin—marking an important step toward product-driven revenue.
Read more: dyadic.com/dyadic-applied…
$DYAI #biotech #lifesciences
English















